Methylprednisolone Sodium Succinate for Injection is mainly used intravenously with a recommended dose of 30mg/kg for the treatment of anti-inflammatory, dermatological diseases, tumors, and allergic states.
Methylprednisolone sodium succinate for injection is mainly used for intravenous injection, and the recommended clinical dose is generally 30mg/kg. methylprednisolone sodium succinate for injection is mainly used in the treatment of anti-inflammatory, dermatological diseases, tumors, allergic states, and rejection reactions after organ transplantation, and can also be used in the treatment of acute adrenocortical insufficiency, surgical shock, and so on.
Some patients using Injection Methylprednisolone Sodium Succinate may have adverse reactions such as protruding eyes, cardiac arrhythmia, hypertension, water-electrolyte disorders, infections, osteoporosis, and so on. It is contraindicated in patients with hypersensitivity to this drug, patients with systemic mycobacterial infections. Note that the drug has an immunosuppressive effect, increased susceptibility to infection, so patients who are using immunosuppressive drugs at the same time need to be closely observed.
Methylprednisolone sodium succinate for injection should be used in accordance with medical advice.